Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration

Experimental Neurology

Volumn 271, Issue , 2015, Pages 401-408

  Remus, Ebony Washington ^a   Sayeed, Iqbal ^a   Won, Soonmi ^a   Lyle, Alicia N ^b   Stein, Donald G ^a  

^a EMORY UNIVERSITY   (United States)

^b CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

Brain ischemia; Cerebrovascular repair; Endothelial cells; Macrophage infiltration; Progesterone

Indexed keywords

CXCL1 CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGESTERONE; CCL2 PROTEIN, RAT; CD68 ANTIGEN, HUMAN; CXCL1 PROTEIN, RAT; CYTOKINE; DIFFERENTIATION ANTIGEN; GESTAGEN; KI 67 ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CELL DENSITY; CELL HYPOXIA; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; MACROPHAGE MIGRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MACROPHAGE; METABOLISM; PATHOLOGY; REPERFUSION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL HYPOXIA; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL1; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; KI-67 ANTIGEN; MACROPHAGES; MALE; PROGESTERONE; PROGESTINS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION;

EID: 84937858765     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.07.010     Document Type: Article

References (30)

1. Akcay A., Nguyen Q., Edelstein C.L. Mediators of inflammation in acute kidney injury. Mediat. Inflamm. 2009, 2009:137072.
2. Cao Y., Hong A., Schulten H., Post M.J. Update on therapeutic neovascularization. Cardiovasc. Res. 2005, 65:639-648.
3. Chandrasekar B., Smith J.B., Freeman G.L. Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001, 103:2296-2302.
4. Diez-Roux G., Lang R.A. Macrophages induce apoptosis in normal cells in vivo. Development 1997, 124:3633-3638.
5. Farivar A.S., Krishnadasan B., Naidu B.V., Woolley S.M., Verrier E.D., Mulligan M.S. Alpha chemokines regulate direct lung ischemia-reperfusion injury. J. Heart Lung Transplant. 2004, 23:585-591.
6. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1:27-31.
7. Frangogiannis N.G. The role of the chemokines in myocardial ischemia and reperfusion. Curr. Vasc. Pharmacol. 2004, 2:163-174.
8. Gibson C.L., Coomber B., Rathbone J. Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke?. Neuroscientist 2009, 15:324-332.
9. Hiu T., Nakagawa S., Hayashi K., et al. Tissue plasminogen activator enhances the hypoxia/reoxygenation-induced impairment of the blood-brain barrier in a primary culture of rat brain endothelial cells. Cell. Mol. Neurobiol. 2008, 28:1139-1146.
10. Ishrat T., Sayeed I., Atif F., Stein D.G. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res. 2009, 1257:94-101.
11. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp. Neurol. 2010, 226:183-190.
12. Ishrat T., Sayeed I., Atif F., Hua F., Stein D.G. Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience 2012, 210:442-450.
13. Jiang C., Wang J., Li X., Liu C., Chen N., Hao Y. Progesterone exerts neuroprotective effects by inhibiting inflammatory response after stroke. Inflamm. Res. 2009, 58:619-624.
14. Kaore S.N., Langade D.K., Yadav V.K., Sharma P., Thawani V.R., Sharma R. Novel actions of progesterone: what we know today and what will be the scenario in the future?. J. Pharm. Pharmacol. 2012, 64:1040-1062.
15. Lambert J.M., Lopez E.F., Lindsey M.L. Macrophage roles following myocardial infarction. Int. J. Cardiol. 2008, 130:147-158.
16. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
17. Morimoto H., Hirose M., Takahashi M., Kawaguchi M., Ise H., Kolattukudy P.E., Yamada M., Ikeda U. MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species. Cardiovasc. Res. 2008, 78:554-562.
18. Nahrendorf M., Pittet M.J., Swirski F.K. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010, 121:2437-2445.
19. Reinhart-King C.A. Endothelial cell adhesion and migration. Methods Enzymol. 2008, 443:45-64.
20. Sayeed I., Guo Q., Hoffman S.W., Stein D.G. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann. Emerg. Med. 2006, 47:381-389.
21. Sayeed I., Wali B., Stein D.G. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor. Neurol. Neurosci. 2007, 25:151-159.
22. Shea-Donohue T., Thomas K., Cody M.J., Aiping Z., Detolla L.J., Kopydlowski K.M., Fukata M., Lira S.A., Vogel S.N. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun. 2008, 14:117-124.
23. Shyy Y.J., Hsieh H.J., Usami S., Chien S. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:4678-4682.
24. Stroo I., Stokman G., Teske G.J., Raven A., Butter L.M., Florquin S., Leemans J.C. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int. Immunol. 2010, 22:433-442.
25. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., Sorg C. Macrophages and angiogenesis. J. Leukoc. Biol. 1994, 55:410-422.
26. Sung F.L., Zhu T.Y., Au-Yeung K.K., Siow Y.L., O K Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int. 2002, 62:1160-1170.
27. Wali B., Ishrat T., Won S., Stein D.G., Sayeed I. Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study. Brain 2014, 137:486-502.
28. Wang Z., Tsai L.K., Munasinghe J., Leng Y., Fessler E.B., Chibane F., Leeds P., Chuang D.M. Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke. Stroke 2012, 43:2430-2436.
29. Won S., Lee J.H., Wali B., Stein D.G., Sayeed I. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway. J. Cereb. Blood Flow Metab. 2014, 34:72-80.
30. Yousuf S., Sayeed I., Atif F., Tang H., Wang J., Stein D.G. Delayed progesterone treatment reduces brain infarction and improves functional outcomes after ischemic stroke: a time-window study in middle-aged rats. J. Cereb. Blood Flow Metab. 2014, 34:297-306.